Ventas, Inc. – Consensus ‘buy’ rating and 14.0% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Ventas, Inc. with ticker code (VTR) have now 18 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $58.00 and $47.00 calculating the mean target price we have $50.72. Given that the stocks previous close was at $44.51 this would indicate that there is a potential upside of 14.0%. The 50 day moving average now sits at $42.60 and the 200 moving average now moves to $45.27. The total market capitalization for the company now stands at 17.89B. The stock price is currently at: $44.46 USD

The potential market cap would be $20,385,836,312 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 2223, revenue per share of $10.87 and a 1.58% return on assets.

Ventas, Inc. is a real estate investment trust (REIT). The Company is engaged in operating at the intersection of healthcare and real estate. It has a portfolio of senior housing communities, medical office buildings (MOBs), life science, research and innovation centers, hospitals and other healthcare facilities. The Company’s segments include Triple-Net Leased Properties, Senior Housing Operating Portfolio (SHOP), and Office Operations. Triple-Net Leased Properties is engaged in investing in and owning senior housing and healthcare properties throughout the United States and the United Kingdom and leasing those properties to healthcare operating companies under triple-net or absolute-net leases. The Senior Housing Operating Portfolio (SHOP) segment invests in senior housing communities throughout the United States and Canada. The Office Operations segment acquires, owns, develops, leases and manages MOBs and life science, research and innovation centers throughout the United States.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search